Alpha Tau Financials

DRTSW Stock  USD 0.23  0.03  15.00%   
Based on the key indicators related to Alpha Tau's liquidity, profitability, solvency, and operating efficiency, Alpha Tau Medical is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April. At this time, Alpha Tau's Non Currrent Assets Other are fairly stable compared to the past year. Cash And Short Term Investments is likely to climb to about 64.4 M in 2025, whereas Other Current Liabilities is likely to drop slightly above 2.6 M in 2025. Key indicators impacting Alpha Tau's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio7.037.4039
Notably Down
Slightly volatile
Investors should never underestimate Alpha Tau's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Alpha Tau's cash flow, debt, and profitability to make informed and accurate decisions about investing in Alpha Tau Medical.

Net Income

(33.34 Million)

  
Understanding current and past Alpha Tau Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Alpha Tau's financial statements are interrelated, with each one affecting the others. For example, an increase in Alpha Tau's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Alpha Tau's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Alpha Tau Medical. Check Alpha Tau's Beneish M Score to see the likelihood of Alpha Tau's management manipulating its earnings.

Alpha Tau Stock Summary

Alpha Tau competes with Alpha Tau. Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of solid cancer In Israel and the United States. The company was founded in 2015 and is headquartered in Jerusalem, Israel. Alpha Tau is traded on NASDAQ Exchange in the United States.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
CUSIP42228C119 M0740A116
LocationIsrael
Business AddressKiryat Hamada Street
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.alphatau.com
Phone972 3 577 4115
CurrencyUSD - US Dollar

Alpha Tau Key Financial Ratios

Alpha Tau Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets53.0M42.2M120.1M107.4M86.2M80.8M
Other Current Liab1.1M3.2M1.6M3.5M4.1M2.6M
Net Debt38.4M30.7M(643K)619K(1.2M)(1.1M)
Retained Earnings(25.6M)(52.8M)(86.6M)(115.8M)(147.5M)(140.1M)
Accounts Payable964K1.2M1.4M2.6M3.5M1.9M
Cash15.6M23.2M5.8M12.7M13.7M13.4M
Net Receivables5K707K1.1M19K332K363.2K
Inventory(29.8M)(8.2M)(1.1M)(19K)(21.9K)(22.9K)
Other Current Assets1.4M1.3M1.9M4.0M4.3M2.4M
Total Liab61.4M77.0M14.5M22.9M23.5M30.8M
Net Invested Capital(8.4M)(34.8M)105.7M90.1M68.2M40.4M
Total Current Assets47.5M32.6M106.5M85.8M64.2M67.2M
Net Working Capital45.4M28.2M102.1M78.7M55.6M62.0M

Alpha Tau Key Income Statement Accounts

The reason investors look at the income statement is to determine what Alpha Tau's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
202020212022202320242025 (projected)
Tax Provision158K7K20K16K6K5.7K
Net Interest Income622K195K1.8M4.7M3.9M2.2M
Interest Income613K211K1.8M4.8M4.3M2.3M
Interest Expense217K12.7M1.8M39K303K287.9K
Operating Income(9.2M)(13.8M)(32.1M)35.7M(36.0M)(34.2M)
Ebit(9.2M)(13.8M)(32.1M)(29.1M)(26.2M)(27.5M)
Research Development7.5M11.4M20.9M26.4M27.0M18.3M
Ebitda(9.2M)(13.0M)(31.2M)(28.0M)(25.2M)(26.5M)
Income Before Tax(8.7M)(27.3M)(33.7M)(29.1M)(31.7M)(33.3M)
Net Income(8.9M)(27.3M)(33.8M)(29.2M)(31.8M)(33.3M)
Income Tax Expense158K7K20K16K14.4K13.7K

Alpha Tau Key Cash Accounts

202020212022202320242025 (projected)
Investments(7.8M)19.3M(89.9M)18.7M20.8M21.8M
Change In Cash14.3M7.7M(17.2M)6.0M1.1M1.1M
Stock Based Compensation596K812K6.7M7.9M9.9M10.4M
Free Cash Flow(11.0M)(14.7M)(24.8M)(24.4M)(22.0M)(23.1M)
Change In Working Capital899K585K(307K)2.5M1.2M875.1K
Begin Period Cash Flow1.8M16.2M23.9M6.7M12.7M13.7M
Other Cashflows From Financing Activities29.3M111K96.9M49K25K23.8K
Depreciation86K776K979K1.1M1.1M748.6K
Other Non Cash Items(153K)29K2.5M8.6M(219K)(208.1K)
Capital Expenditures3.8M2.9M904K6.4M2.2M3.2M
Total Cash From Operating Activities(7.3M)(11.8M)(23.9M)(18.0M)(19.8M)(20.8M)
Net Income(8.9M)(27.3M)(33.8M)(29.2M)(31.8M)(33.3M)
Total Cash From Financing Activities29.3M111K96.9M5.3M25K23.8K
End Period Cash Flow16.2M23.9M6.7M12.7M13.7M13.7M

Alpha Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Alpha Tau's current stock value. Our valuation model uses many indicators to compare Alpha Tau value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alpha Tau competition to find correlations between indicators driving Alpha Tau's intrinsic value. More Info.
Alpha Tau Medical is rated # 2 in return on equity category among its peers. It also is rated # 2 in return on asset category among its peers . At this time, Alpha Tau's Return On Equity is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Alpha Tau by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Alpha Tau Medical Systematic Risk

Alpha Tau's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Alpha Tau volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Alpha Tau Medical correlated with the market. If Beta is less than 0 Alpha Tau generally moves in the opposite direction as compared to the market. If Alpha Tau Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Alpha Tau Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Alpha Tau is generally in the same direction as the market. If Beta > 1 Alpha Tau moves generally in the same direction as, but more than the movement of the benchmark.

Steps to analyze company Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Alpha Tau is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Alpha has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Alpha Tau's financials are consistent with your investment objective using the following steps:
  • Review Alpha Tau's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Alpha Tau's liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Alpha Tau's financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Alpha Tau's stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

Alpha Tau Thematic Clasifications

Alpha Tau Medical is part of Medical Equipment investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
Medical EquipmentView
This theme covers USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in Alpha Tau Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Alpha Tau's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Alpha Tau growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.33

At this time, Alpha Tau's Price Earnings To Growth Ratio is fairly stable compared to the past year.

Alpha Tau March 22, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Alpha Tau help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Alpha Tau Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Alpha Tau Medical based on widely used predictive technical indicators. In general, we focus on analyzing Alpha Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Alpha Tau's daily price indicators and compare them against related drivers.

Additional Tools for Alpha Stock Analysis

When running Alpha Tau's price analysis, check to measure Alpha Tau's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alpha Tau is operating at the current time. Most of Alpha Tau's value examination focuses on studying past and present price action to predict the probability of Alpha Tau's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alpha Tau's price. Additionally, you may evaluate how the addition of Alpha Tau to your portfolios can decrease your overall portfolio volatility.